INCRELEX
Google image searchProduct monograph
Active ingredient
mecasermin, 40 MG/4 ML
DIN: 02509733
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: MULTI-DOSE VIAL
Schedule: Prescription / Schedule D
Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Date: 01-MAR-2021
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01A — ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES (ATC, ATC/DDD)
- H01AC — Somatropin and somatropin agonists (ATC, ATC/DDD)
- H01AC03 — MECASERMIN (ATC/DDD)
Reference brand drug: Increlex
